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Abstract
Retinal vascular caliber provides information about the structure and health of the microvascular system and is associated
with cardiovascular and cerebrovascular diseases. Compared to European Americans, African Americans tend to have wider
retinal arteriolar and venular caliber, even after controlling for cardiovascular risk factors. This has suggested the hypothesis
that differences in genetic background may contribute to racial/ethnic differences in retinal vascular caliber. Using 1,365
ancestry-informative SNPs, we estimated the percentage of African ancestry (PAA) and conducted genome-wide admixture
mapping scans in 1,737 African Americans from the Atherosclerosis Risk in Communities (ARIC) study. Central retinal artery
equivalent (CRAE) and central retinal vein equivalent (CRVE) representing summary measures of retinal arteriolar and
venular caliber, respectively, were measured from retinal photographs. PAA was significantly correlated with CRVE
(r=0.071, P=0.003), but not CRAE (r=0.032, P=0.182). Using admixture mapping, we did not detect significant admixture
association with either CRAE (genome-wide score=20.73) or CRVE (genome-wide score=20.69). An a priori subgroup
analysis among hypertensive individuals detected a genome-wide significant association of CRVE with greater African
ancestry at chromosome 6p21.1 (genome-wide score=2.31, locus-specific LOD=5.47). Each additional copy of an African
ancestral allele at the 6p21.1 peak was associated with an average increase in CRVE of 6.14 mm in the hypertensives, but had
no significant effects in the non-hypertensives (P for heterogeneity ,0.001). Further mapping in the 6p21.1 region may
uncover novel genetic variants affecting retinal vascular caliber and further insights into the interaction between genetic
effects of the microvascular system and hypertension.
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Introduction
Changes in retinal vascular caliber provide unique information
regarding the structure and state of the microvasculature in the
eye, possibly reflecting pathophysiological processes in the
microvascular systems elsewhere in the body. Narrowed retinal
arteriolar caliber has been known to be predictive of hypertension
[1,2] and coronary heart disease [3], while wider retinal venular
caliber is associated with higher blood pressure [4,5], impaired
fasting glucose, diabetes, dyslipidemia [6–8], and risk of coronary
heart disease [9]. In particular, because retinal vessels share
embryological, anatomical and physiologic characteristics with
cerebral vessels [10], wider retinal venular caliber bas been closely
linked to both subclinical and clinical cerebrovascular diseases,
including lacunar infarction, white matter lesions, clinical stroke
[9,11,12] and cerebral hypoxia [13].
Retinal vascular caliber has been observed to vary between
racial/ethnic groups. In the Multi-Ethnic Study of Atherosclerosis,
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venular caliber compared to Whites and Asian Americans, even
after controlling for cardiovascular risk factors [8]. In the
Atherosclerosis Risk in Communities (ARIC) Study and Cardio-
vascular Health Study, African Americans had larger retinal
arteriolar and venular calibers than European Americans while
controlling for age, gender and mean arterial blood pressure
[Wong TY, unpublished data, 2009]. The underlying reasons for
this racial/ethnic difference are unclear and might be related to
systemic, environmental, and measurement factors [14,15].
However, several lines of evidence provide support for genetic
factors also being involved in the regulation of retinal vascular
caliber. The heritability of retinal arteriolar and venular caliber
was estimated to be 0.48 and 0.54, respectively, in the Beaver Dam
Eye Study [16]. Results from two twin studies also showed retinal
vascular caliber may be primarily determined by genetic influence
with the heritability of 0.57–0.70 for arteriolar caliber and
0.62–0.83 for venular caliber [17,18]. The observed racial/ethnic
differences in retinal vascular caliber could not be fully explained
by systemic and environmental factors alone, which prompted our
hypothesis that differences in genetic background may partially
account for differences in retinal vascular caliber across racial/
ethnic populations.
To identify chromosomal regions which may harbor genes that
modulate retinal vascular caliber, we utilized admixture mapping,
a technique that scans the genomes in recently admixed
populations, such as African Americans, for regions which may
contain variants that not only differ in frequencies between the two
genetically diverse ancestral populations (Europeans and West
Africans in this case), but can also partially explain differences in
phenotypes between populations [19–24]. Since the identification
of ancestry-informative markers and the development of appro-
priate statistical methods for admixture analysis in African
Americans [23], admixture mapping and subsequent fine-mapping
studies have has been successful in identifying determinant genetic
variants for prostate cancer [25,26], end stage renal disease
(ESRD) [27], white blood cell count [28,29], and the circulating
levels of interleukin 6 and interleukin 6 soluble receptor [30].
Differences in retinal vascular caliber between African Americans
and European Americans make this an ideal phenotype to study
with the admixture mapping approach.
The main hypothesis of the present study was that some alleles
affecting retinal vascular caliber are present at higher frequency in
Africans than Europeans. We thus conducted a genome-wide
admixture mapping scan for retinal arteriolar and venular caliber
using approximately 1,365 ancestry informative markers in self-
identified blacks from the ARIC study. In addition, hypertension is
known as one of the most important risk factors for cardiovascular
and cerebrovascular diseases. Previous studies indicated the
importance of interactive effects between genes and vascular risk
factors, in particular hypertension, on the occurrence of
cardiovascular diseases [31–33] and cerebrovascular disorders
[34–36]. It has been suggested that studies investigating the role of
genetic components in vascular diseases would be more effective
by analyzing interaction of genetic effects with conventional risk
factors [35]. Therefore, a secondary purpose of our study was to
test the hypothesis that the effect of genetic variants that conferred
differences in retinal vascular caliber in African Americans was
modified by hypertension.
Results
Central retinal artery equivalent (CRAE) and central retinal
vein equivalent (CRVE) were measured from retinal photographs
of study subjects in the ARIC study to represent the average
retinal arteriolar and venular caliber, respectively (see Methods).
Table 1 shows demographic and phenotypic characteristics of the
1,737 African Americans included in the present study by
hypertensive status. Of them, 1,001 (57.9%) had hypertension.
The estimated percentage of African ancestry (PAA) in the
African-American subjects was 82.469.8%.
Correlations of retinal vascular caliber and genetic
ancestry
The correlations between retinal vascular caliber and PAA are
shown on Figure 1. CRVE was significantly correlated with PAA
(correlation coefficient, r=0.071, P=0.003), while the correlation
between PAA and CRAE was weaker and not statistically
significant (r=0.032, P=0.182). To assess the potential interac-
tion between genetic effects and hypertension, we examined the
correlations limited to hypertensive individuals as an a priori
subgroup analysis. We found that among hypertensive individuals,
the correlations with PAA became stronger for both CRAE
(r=0.084, P=0.008) and CRVE (r=0.094, P=0.003).
Initial admixture mapping scans
We carried out genome-wide admixture mapping scans for both
CRAE and CRVE using case-only and case-control approaches,
using up to 1,365 ancestry-informative SNP markers. Cases
(N=261) and controls (N=260) for CRAE were defined as the
extreme 15% of samples with narrowest caliber and the 15% with
widest caliber, respectively, after adjustment for age, sex, study
site, 6-year mean blood pressure, and fasting glucose level. For
CRVE, the extreme 15% of samples with widest caliber was
defined as cases (N=260), while the extreme 15% with narrowest
caliber as controls (N=261). The mean CRAE was 46.2 mm
(615.3) narrower in cases compared to controls. On the other
hand, the mean CRVE was 51.0 mm( 616.1) wider in cases
compared to controls. Using 18 pre-specified European ancestry
risk models, we did not detect significant admixture association
with either CRAE or CRVE (Table S1). The genome-wide score,
derived by averaging the evidence of association across all loci
Author Summary
Retinal vessels provide a window to microvascular systems
elsewhere in the body. The diameter of retinal vessels
varies between racial/ethnic groups, being generally wider
in African Americans compared to European Americans. To
determine whether genetic background may contribute to
this observed difference, we scanned the entire genomes
of 1,737 African Americans, searching for genomic regions
where individuals with either wider retinal venular or
narrower retinal arteriolar caliber have a difference from
the average percentage of African ancestry. We find that
the percentage of African ancestry is positively correlated
with retinal venular caliber, particularly in the hypertensive
individuals. We detect substantive evidence of association
between excess African ancestry and wider retinal venular
caliber on chromosome 6p21.1 in the hypertensives, but
not in the non-hypertensives. The 6p21.1 region contains
genes that are known to be involved in development and
modulation and of retinal vessels. Our results suggest that
genetic factors may contribute to the observed difference
in retinal vascular caliber between African Americans and
European Americans. Further fine-mapping studies of the
genomic region may identify variants affecting retinal
vascular caliber.
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CRVE (Table 2), which did not meet the thresholds of .2 for
genome-wide significance [37].
Significant admixture-generated signal for retinal venular
caliber in the hypertensive group
To examine whether hypertension modified the effects of
genetic ancestry on retinal vascular caliber, we performed
admixture mapping scans by hypertension status. Cases and
controls were defined as the extreme 15% (after adjustment for the
covariates as described above) in the hypertensive subset and
included about 150 subjects in each group. On average, CRAE
was 46.5 mm( 615.5) narrower and CRVE was 51.6 mm( 616.7)
wider in the cases, compared to the controls. We found genome-
wide significant evidence of associations with CRVE in the
hypertensive subset (Table 2). The genome-wide score in the case-
only analysis was 2.31, which meets our threshold of .2 for
significance. The strongest admixture association for CRVE was
observed at 6p21.1 (42.5 Mb on chromosome 6 in build 35 of the
human genome reference sequence; Figure 2), with the peak locus-
specific LOD of 5.47, again reaching our priori defined thresholds
of .5 for significance [37]. To further correct for the multiple
hypothesis testing in two subgroups, we divided our test statistic,
which is the likelihood ratio that compares the model under a risk
model to the null model by 2. The likelihood ratio was
10
5.47=295120.9. The likelihood ratio after corrected for two
hypothesis testing was 295120.9/2=147560.5, corresponding to a
LOD score of 5.17, which still exceeds the threshold of .5 for
significance. No other locus exceeded a LOD score of 5.
To evaluate the stability of our results, we carried out a longer
analysis with 10-times more iterations in our Markov Chain
Monte Carlo run. We obtained a similar strength of signal with a
genome-wide score of 2.28 and a peak locus-specific LOD of 5.43
at the same location. The risk model with the strongest score
corresponded to a risk of 0.5 due to one copy of an European
ancestral allele with the inverse risk for carrying zero copies (see
Methods for the set of risk models). Further refining the risk
models, we obtain a genome-wide score of 3.66 and a locus-
specific LOD of 6.85 in this region.
The admixture-generated signal for CRVE in the hypertensive
subset was further supported by the case-control analysis. At the
6p21.1 peak, the cases had a highly statistically significant increase in
African ancestry compared to controls (case-control Z score=25.26,
P=1.44 610
27; Figure 2). The association was nominally genome-
wide significant (P=2.88 610
24) after conservatively correcting for
multiplehypothesistesting(bymultiplyingby2,000becausewetested
1,000 independent chromosomal chunks in two subgroups).
We did not find any significant associations with CRAE in the
hypertensive subset (genome-wide score=0.18). The highest locus-
specific LOD was 2.37, arising from chromosome 5, followed by
the second highest LOD of 2.04 on chromosome 6 (Figure S1).
Admixture scans were also carried out in the non-hypertensive
subset, but we did not observe any evidence of association with
either CRAE (genome-wide score=20.40) or CRVE (genome-
wide score=20.21; Table 2).
Evidence of association between admixture-generated
signals and continuous CRVE and interaction with
hypertension
To further assess the robustness of the admixture-generated
signal, we extracted the local estimate of African ancestry at the
6p21.1peak, and tested for association with continuous CRVE by
hypertension status. This enabled us to increase power by
including all samples in a quantitative analysis. We carried out a
series of linear regression analysis, with the normal-quantile
transformed CRVE (after adjusted for covariates as described
above) as a dependent variable and the local ancestry as an
independent variable. As shown in Table 3, local African ancestry
alone was strongly associated with the transformed CRVE in the
hypertensive subset (P=2.9610
28; Model 1). To assess whether
continuous CRVE was associated with local ancestry at 6p21.1
due to their associations with global ancestry (i.e., PAA), we
modeled the transformed CRVE as a function of local, global and
regional ancestry. We found that the residual association of local
ancestry with the transformed CRVE after adjustment for both
global and regional ancestry remained significant (P=3.9610
26),
indicating that there may be a gene in the region of 6p21.1 that is
associated with CRVE above and beyond the fact that variants in
this locus are highly differentiated between ancestral populations
and thus correlated with global ancestry. The association was
nominally genome-wide significant (P=7.8610
23) after correcting
for multiple hypotheses tested (by multiplying by 2,000). The
results were similar when CRVE was additionally adjusted for
other covariates (Model 2), including high-density lipoprotein
(HDL) cholesterol, low-density lipoprotein (LDL) cholesterol and
plasma triglyceride levels, body mass index (BMI), smoking, and
alcohol consumption. We estimated that each additional copy of
Table 1. Characteristics of the study participants by
hypertension status.
Characteristics
With
hypertension
(N=1001)
Without
hypertension
(N=736)
All
(N=1737)
Age, y 59.065.5 57.565.1
a 58.365.4
Female, % 66.3 59.8
a 63.6
Percentage of African
ancestry, %
83.069.3 81.5610.7
a 82.469.8
CRAE, mm 162.8615.6 167.6615.5
a 164.8615.7
CRVE, mm 199.4616.7 199.9616.3 199.6616.5
6-year mean arterial blood
pressure
b, mmHg
98.5610.2 87.167.4
a 93.7610.7
Fasting glucose, mg/dL 118.9647.1 108.4637.6
a 114.5643.6
HDL cholesterol, mg/dL 54.9618.3 57.1618.5
a 55.8618.4
LDL cholesterol, mg/dL 129.5636.7 127.6636.9 128.7636.8
Triglyceride, mg/dL 119.0669.8 103.4659.8
a 112.4666.2
Body mass index, kg/m
2 31.466.4 29.066.0
a 30.466.3
Diabetes, % 23.4 13.0
a 19.0
Cigarette smoking, %
Current 18.9 22.1 20.3
Former 32.7 32.6 32.6
Never 47.4 45.1 46.4
Alcohol consumption, %
Current 29.0 35.9
a 31.9
Former 31.0 28.0 29.7
Never 39.0 36.0 37.7
CRAE, central retinal artery equivalent; CRVE, central retinal vein equivalent.
Data are mean 6 SD, except for sex, diabetes, cigarette smoking and alcohol
consumption, which are presented as percentage, %.
a P,0.05 for difference between participants with and without hypertension.
b Mean arterial pressure, defined as 2/3 diastolic plus 1/3 systolic blood
pressure, across the three AIRC visits was averaged to obtain the 6-year mean
arterial pressure.
doi:10.1371/journal.pgen.1000908.t001
Admixture Mapping of Retinal Vascular Caliber
PLoS Genetics | www.plosgenetics.org 3 April 2010 | Volume 6 | Issue 4 | e1000908Figure 1. Correlation of retinal vascular calibers and the estimated percentage of African ancestry in the ARIC African Americans.
Data are scatter-plotted for (A) central retinal artery equivalent in all individuals, (B) central retinal vein equivalent in all individuals, (C) central retinal
artery equivalent in hypertensive individuals, and (D) central retinal vein equivalent in hypertensive individuals. The solid black line in the figure is a
linear regression line.
doi:10.1371/journal.pgen.1000908.g001
Table 2. Summary of locus-specific scores from the admixture scans of retinal vascular caliber.
Samples and traits
a
No. of
SNPs
No. of
samples
No. of
cases/controls
b
Genome-wide
score
Locus-specific LOD
at Chr. 6 peak
All African Americans
CRAE 1356 1737 261/260 20.73 0.41
CRVE 1365 1737 260/261 20.69 1.45
Hypertensive African Americans
CRAE 1350 1001 151/150 0.18 2.04
CRVE 1359 1001 150/151 2.31
c 5.47
d
Non-hypertensive African Americans
CRAE 1356 736 110/109 20.40 0.42
CRVE 1357 736 109/110 20.21 20.51
CRAE, central retinal artery equivalent; CRVE, central retinal vein equivalent.
a Both CRAE and CRVE were adjusted for age, sex, study site, 6-year mean arterial pressure and fasting glucose level.
b For CRAE, cases were defined as the 15% with the lowest covariate-adjusted values, and controls were the 15% with the highest covariate-adjusted values. For CRVE,
cases were defined as the 15% with the highest covariate-adjusted values, and controls were the 15% with the lowest covariate-adjusted values.
c Genome-wide scores .2 are formally significant.
d Locus-specific LOD scores .5 are formally significant.
doi:10.1371/journal.pgen.1000908.t002
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CRVE increase of 0.37 Z-score units on average (equivalent to
,6.14 mm).
In contrast, in the non-hypertensive subset, the local ancestry
effect at the 6p21.1 peak on CRVE was weak and did not reach
significance (Table 3). The effect of local ancestry showed
significant heterogeneity (P,0.001) between the hypertensive
and non-hypertensive groups, which was in line with the results
of the above dichotomous admixture scans.
95% credible interval for the CRVE loci
Given the significant statistical evidence for peak at 6p21.1, we
constructed 95% credible interval (CI) for the loci identified. The
95% CI spanned from 40.8 to 43.9 Mb on build 35 of the human
genome reference sequence (Figure S2). The locus-specific LOD
score and the association of the CRVE to local ancestry for
the SNPs located near and within the 95% CI are presented in
Table S2.
Discussion
We used admixture mapping to search for genomic regions that
may account for inter-individual variations in retinal vascular
caliber. We found evidence for association with retinal venular
caliber at 6p21.1 in hypertensive African Americans and observed
concordant results when venular caliber was examined as a
continuous variable, with higher levels of African ancestry being
significantly associated with wider retinal venular caliber. The
significant evidence of association with the local ancestry at the
6p21.1 peak was above and beyond the contribution of both global
and regional ancestry. Methodologically, these results are
interesting in that subset analysis was required in order to detect
the association. We note that subsets analysis has previously been
very successful in admixture mapping. For prostate cancer, the
chromosome 8q24 locus was not detected until the analysis was
limited to a subset of individuals with a younger age at diagnosis
[25]. For ESRD, the admixture signal to be much stronger among
non-diabetic ESRD (mainly hypertensive ESRD) only, compared
Figure 2. Genome-wide admixture mapping scans for loci affecting retinal venular caliber in hypertensive individuals. For case-only
analysis (LOD score, red line), the genome-wide score was 2.31, reaching the threshold of .2 for significance. The highest locus-specific LOD of 5.47
was detected at 6p21.1, and this score again met the threshold of .5 for significance. The admixture-generated signal was further supported by case-
control analysis (Z score, blue gray line). At the 6p21.1 peak, the cases had highly significantly lower percentage of European ancestry than the
controls (case-control Z score=25.26, P=1.44610
27).
doi:10.1371/journal.pgen.1000908.g002
Table 3. Linear regression analysis of CRVE on local African ancestry on the chromosome 6 peak by hypertension status.
Model 1
a Model 2
b
African ancestry and hypertension status
Reg.
Coef.
c (95% CI) P value
Reg.
Coef.
c (95% CI) P value
Hypertensive African Americans (n=1001)
Local ancestry only 0.36 (0.23, 0.48) 2.9610
28 0.35 (0.22, 0.48) 7.5610
28
Local ancestry, global ancestry as a covariate 0.34 (0.21, 0.48) 7.9610
27 0.34 (0.20, 0.48) 1.6610
26
Local ancestry, global ancestry and regional ancestry covariates 0.38 (0.22, 0.55) 3.9610
26 0.37 (0.21, 0.54) 1.1610
25
Non-hypertensive African Americans (n=736)
Local ancestry only 20.09 (20.24, 0.06) 0.238 20.08 (20.23, 0.07) 0.289
Local ancestry, global ancestry as a covariate 20.16 (20.32, 0.01) 0.062 20.18 (20.34, 20.01) 0.036
Local ancestry, global ancestry and regional ancestry covariates 20.12 (20.32, 0.07) 0.217 20.14 (20.33, 0.06) 0.170
Heterogeneity between groups
d P=9.2 610
25 P=9.5 610
25
CRVE, central retinal vein equivalent; Reg. Coef., regression coefficient of the local ancestry; CI, confidence interval.
a CRVE was adjusted for age, sex and study site, 6-year mean arterial pressure and fasting glucose level, and then normal-quantile transformed.
b In addition to the variables included in Model 1, CRVE was further adjusted for HDL cholesterol level, LDL cholesterol level, plasma triglyceride level, body mass index,
smoking, and alcohol consumption, and then normal-quantile transformed.
c The change in Z score for each additional copy of the local ancestry allele.
d By Z test for difference between the two the regression coefficients from the hypertensive and non-hypertensive groups in the models with both global and regional
ancestry as covariates.
doi:10.1371/journal.pgen.1000908.t003
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genetic variants strongly associated with both prostate cancer [26]
and non-diabetic ESRD [27]. We hope to follow up the present
analysis with successful fine-mapping as well.
Our findings in persons with hypertension in the subgroup
analysis imply that genes associated with hypertension may have
exerted their effects on retinal vascular caliber. While we cannot
exclude the possibility of a chance finding, we were able to show
consistent results in the local ancestry analysis, which included the
total population. Furthermore, from a physiological perspective,
our finding that there is a genetic association with retinal venular
caliber specifically in people with hypertension is sensible.
Hypertension is known to have profound effects on the retinal
microcirculation [38–40], and may induce gene expression
relevant to the modulation of retinal vessels (see further discussion
below) [41]. Our findings are also in line with previous studies in
other vascular diseases that indicated hypertension exaggerates the
effects from genetic factors [31–36].
In hypertensive persons, we detected significant genetic
association for retinal venular caliber, but not arteriolar caliber.
Because retinal arterioles and venules likely possess distinct genetic
determinants [42], there may be no common genetic variants with
a strong effect accounting for differences in retinal arteriolar
caliber between European and African populations. Moreover, a
diminished capability of retinal arterioles to remodel because of
progressive sclerosis and rigidity of arteriolar vessel walls with age
[43,44] may have precluded a degree of change in arteriolar
caliber equal to that observed in venular caliber.
To our knowledge, there have been only two prior studies
examining the genetic basis of retinal vascular caliber with a
genome-wide approach, and both of them used linkage analysis
[18,45]. By genotyping 385 microsatellite markers in the Beaver
Dam Eye Study, Xing et al. [45] found several loci for CRAE and
CRVE, with the most significant loci at 3q28 (empirical
P=1.2610
24) and 8q21 (empirical P=2.9610
23), respectively.
A recent linkage analysis in the Australian Twins Eye Study
identified 8p23.1 (LOD=2.24) and 2p14 (LOD=2.69) as
suggestive loci for CRAE and CRVE, respectively [18]. Although
findings of the two linkage analyses were not replicated in our
study, possibly due to differences in study design and popula-
tions, all three studies provide lines of evidence that structural
changes in the microvasculature of retina may have genetic
determinants.
One major concern of the present study is a potential
measurement error on retinal vascular caliber itself, which has
been suggested to account for some of the observed racial/ethnic
difference in retinal caliber [15]. A recent report suggested that
retinal pigmentation could be a source of error in the computer-
assisted methods to measure retinal vascular caliber from
photographs [15]. The study reported that arteriolar and venular
calibers were significantly wider in East Asian children than their
white counterparts. However, when the analysis was confined to
children with dark brown iris (a surrogate of retinal pigmentation)
only, the differences between racial groups were less pronounced.
Nevertheless, measurement errors are less likely to bias results in
the present study for the following reasons. First, in the ARIC
study, the retinal vessel edge was not detected based on computer-
generated pixel density curve, but located manually by graders
[46]. We believe the manual grading of retinal vascular caliber
would be less prone to bias than computerized grading schemes,
yet this remains to be proved. Second, genetic ancestry was shown
to be significantly correlated with human pigmentation [47].
Although we did not measure skin or retinal pigmentation in the
ARIC study, the inclusion of global ancestry as a covariate in our
local ancestry analysis (Table 3) may thus provide an alternative
way to adjust for the differences in retinal pigmentation.
The 95% CI for the 6p21.1 locus, a ,3.1 Mb region, contains
genes that may have biological relevance to the development and
modulation and of retinal vessels (Figure S2). One such gene is the
vascular endothelial growth factor (VEGF) gene. VEGF is an
endothelial-cell selective mitogen intimately associated with
vasculogenesis, angiogenesis and vascular permeability. In the
retina, VEGF plays a crucial role in the induction of retinal
vasculature and its expression is regulated by hypoxia during
embryonic development [48]. Moreover, animal experiments
showed that VEGF acts as a survival factor for newly formed
retinal vessels [49], and it continues to be produced by retinal
astrocytes and pericytes in the vicinity of retinal vessels in adults
[50]. Interestingly, mechanical stretch on retinal vessel endothe-
lium induced by systemic hypertension could increase the
expression of VEGF and its receptor [41]. Further mapping work
is needed to determine whether variants in the VEGF gene indeed
contribute to variations in retinal vascular caliber. If proven, this
may help explain why we detected the association at 6p21.1 only
in hypertensive persons.
In addition to VEGF, there are two other genes in the 95% CI
that may potentially be associated with retinal phenotype:
peripherin 2 (PRPH2/RDS) and guanylate cyclase activator 1A
(GUCA1A), both of which are also expressed in retina [51,52].
GUCA1A plays a role in the recovery of retinal photoreceptors
from photobleaching [52]. PRPH2/RDS is mainly located in the
outer segment of both rod and cone, and defects in this gene are
associated with retinal degenerations [51]. VEGF appears to be the
strongest candidate gene based on its known function. However, it
does not exclude the possibility that the admixture-generated
signal is due to other genes.
The human leukocyte antigen (HLA) loci, located on chromo-
some 6p21.3 and about 10 Mb away from the 95% CI, are gene-
rich and highly polymorphic [53]. The HLA region has been
shown to play an important role in multiple disease susceptibility,
particularly in autoimmune and infectious diseases [54]. HLA
alleles are strongly associated with many neighboring SNPs,
sometimes located at a considerable distance from the HLA allele
with the linkage disequilibrium (LD) extending several Mb [55]. It
remains to be determined whether the HLA alleles and the alleles
in the 95% CI are in LD and may thus be associated with retinal
venular caliber.
In summary, using a genome-wide admixture mapping scan in
1,737 African Americans, we detected a risk locus influencing
retinal vascular caliber in hypertensive individuals at 6p21.1,
where the association between local ancestry and retinal venular
caliber was strong, suggesting the presence of a genetic effect
beyond the effects of global ancestry. Follow-up fine mapping or
haplotype tagging across the peak will be necessary to determine
whether this region harbors genetic variations that may interact
with hypertension to modulate retinal venular caliber. Under-
standing the genetic basis of retinal vascular caliber may provide
novel insight into the development and remodeling of the
microvasculature in the brain and elsewhere in the body.
Methods
Ethics statement
This study was conducted according to the principles expressed
in the Declaration of Helsinki. All sample collections were carried
out according to institutionally approved protocols for study of
human subjects and written informed consent was obtained from
all subjects.
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Subjects of the present study were from the 2,997 African-
American participants of the ARIC study at the third examination.
The ARIC study is a prospective epidemiologic study that
examines clinical and subclinical atherosclerotic disease in a
cohort of 15,792 persons (including 4,266 African-Americans),
aged 45 to 64 years at their baseline examination. Participants
were selected by probability sampling from four U.S. communi-
ties: Forsyth County, NC (12% African American); Jackson, MS
(100% African American); the northwest suburbs of Minneapolis,
MN (,1% African American); and Washington County, MD
(,1% African American). The sampling procedure and methods
used in ARIC have been described in detail elsewhere [56].
Participants self-reported their ethnicity. The baseline examina-
tion (visit 1) took place from 1987 to 1989, a second examination
(visit 2) from 1990 to 1992, and a third examination (visit 3) from
1993 to 1995. Retinal vascular calibers were measured at visit 3.
Data from visit 3 were used for the present analysis.
The final sample for the present analysis included 1,737 African
Americans after excluding the following samples (N=1,267): 1)
African-American subjects who lived in Minneapolis, MN, or
Washington County, MD, or 2) did not consent to genetic studies
or did not have DNA samples available, 3) samples that were not
genotyped successfully or that failed to pass quality control (see
‘‘Elimination of problematic samples’’), 4) subjects who had no
retinal photographs, ungradable photographs or retinal vascular
occlusions, and 5) subjects who had missing data on the covariates
used in the main admixture mapping scans (see ‘‘Admixture
mapping’’).
Measurement of retinal vascular caliber
The retinal photography procedure and its assessment have
been described in detail elsewhere [46]. Briefly, a 45-degree retinal
photograph of one randomly selected eye of each participant was
taken at visit 3 following 5 minutes of dark adaptation. This
photograph was centered on the region of the optic disc and the
macula and was taken using an autofocus camera.
Trained graders who were masked to participant measured the
calibers of all arterioles and venules coursing through a specified
area surrounding the optic disc according to a standardized
protocol [46]. Individual vessel measurements were combined into
summary indices: CRAE and CRVE. These indices represents
average retinal arteriolar and venular caliber of the eye after
taking into account the branching patterns. These measurements
of retinal vascular calibers are reliable, with generally high
intragrader and intergrader reliability coefficients (0.84 and 0.79,
respectively) [46,57].
Assessment of systemic factors
Current blood pressure was defined as measurements at the time
of retinal photography at visit 3, and 3- and 6- year past blood
pressure was defined as measurement taken at visit 2 and visit 1,
respectively. Mean arterial pressure was defined as two thirds of
diastolic plus one third of systolic blood pressure. Mean arterial
pressure across the three visits was averaged to obtain the 6-year
mean arterial pressure. BMI was calculated as weight (in kg)/height
(in meters) squared. Blood collection and processing followed a
standard protocol [58]. Fasting glucose was assessed by a modified
hexokinase/glucose-6-phosphate dehydrogenase procedure. Total
plasma cholesterol and triglyceride were measured using enzymatic
methods [59]. LDL cholesterol was calculated [60], and HDL
cholesterol was measured after dextran-magnesium precipitation
of non-HDL lipoproteins [58]. Cigarette smoking and alcohol
consumption were ascertained from a questionnaire interview.
Hypertension was defined as current systolic blood pressure $140
mm Hg, diastolic pressure $90 mm Hg, or self-reported use of
medications for high blood pressure during the 2 weeks preceding
the clinic examination at visit 3.
Genotyping for the ancestry informative markers
We genotyped a total of 1,536 SNPs included in the phase 3
admixture panel [28,61]. This panel was constructed by using the
panel of ancestry informative markers previously published by
Smith et al. (phase 1 panel) [24], improving this panel by mining
new ancestry informative markers from the data sets of Hinds et al.
[62] and the Phase 2 International Haplotype Map [63], and then
validating them to confirm that they were indeed ancestry
informative. Genotyping was performed by the Center for
Inherited Disease Research (CIDR, Johns Hopkins University,
Baltimore), using the Illumina BeadLab platform [64]. The ARIC
study has a rigorous quality control program, including blind
duplicates. Many genotypes in duplicates were obtained using the
Illumina BeadLab technologies in ARIC African-American
participants, and CEPH and Yoruban samples. The mismatch
rate among duplicate genotypes was 0.1%.
Estimates of allele frequencies in ancestral populations
We used previously published genotyping data to estimate the
frequency of each SNP in West Africans and Europeans
[24,25,65]. We used only those SNPs for which we were able to
obtain data from both West African (Yoruba) and European
American (CEU) populations from the International Haplotype
Map. For SNPs in the phase 1 panel, we also added additional
genotyping data from African and European samples, which was
the same as the data collected in Smith et al. 2004 [24].
Elimination of problematic samples
After genotyping, samples were eliminated based on the
following criteria: 1) samples with low (,94%) call rate, 2)
samples showing gender mismatch between self-reported data and
genetically estimated gender based on 50 markers on the X
chromosome, and 3) duplicate samples (defined as .75% match
in the genotypes between two samples. Moreover, we used built-in
data checking programs in the ANCESTRYMAP [23] software to
exclude samples with an apparent excess or deficiency of
heterozygous genotypes compared with the expectation from the
individuals’ global ancestry. An apparent excess of heterozygous
genotypes (defined as the Z-score .10) usually indicates the
individuals have parents with divergent ancestries (for example,
one parent who is entirely of European ancestry) and such
individuals nearly always have estimated European ancestry close
to 0.5 [23].
SNP quality filters
To decrease the likelihood of false-positives in our admixture
scans, we applied a series of filters that had the goal of detecting
and removing any SNPs with problematic genotyping, as
described previously [24,30,61,66]. First, SNPs were dropped if
there were atypical clustering patterns, ill-defined clusters, or
relatively low genotyping success rate (95%). This left us with
1,416 SNPs (all with genotyping call rate .97%). We then applied
three previously described filters to further eliminate SNPs from
the analysis [66]. 1) We eliminated SNPs (N=15) if they did not
meet the requirement for Hardy-Weinberg equilibrium (P.0.01)
in both ancestral West African and European populations. 2) We
applied a ‘‘freqcheck’’ filter that examined whether the observed
frequency of a SNP in African Americans was statistically
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West Africans and European American samples that we used to
represent the ancestral populations [23]. 3) Lastly, we applied a
‘‘ldcheck’’ filter that for each sample, iteratively eliminated SNPs
that were less informative (in terms of the information content
about ancestry) until none were within 200 Kbs of each other or in
detectable LD with each other in the ancestral West African or
European populations [23]. After imposing these requirements,
1,365 SNPs were left for analysis.
Estimating genome-wide ancestry genetic ancestry
Using the ANCESTRYMAP software [23], we estimated a
global ancestry for each individual, as indicated by PAA.
ANCESTRYMAP uses a Markov Chain Monte Carlo approach
to account for uncertainty in the unknown parameters (including
SNP allele frequencies in the West African and European ancestral
populations, the number of generations since mixture, and the
average proportion of ancestry inherited from ancestral popula-
tions) that emerge from the Hidden Markov Model analysis. All
Markov Chain Monte Carlo runs used 100 burn-in and 200
follow-on iterations, as recommended [23], except for one longer
run of 1,000 burn-in and 2,000 follow-on iterations, which we used
to check the stability of our results.
Admixture mapping
We used the ANCESTRYMAP software [23] to search for
genomic regions associated with an increased percentage of either
European or African ancestry. The main dichotomous admixture
scans used the values of retinal vascular caliber adjusted using the
following covariates: age, sex, study sites (Forsyth County or
Jackson), 6-year mean arterial blood pressure and fasting glucose
level, because the latter two systemic factors were both significantly
correlated with PAA (both P,0.01) and known to be associated
with retinal vascular calibers [4,7,8]. For the tests for associations
of the local ancestry, we additionally adjusted for other
cardiovascular risk factors.
For the purpose of this dichotomous admixture analysis, study
participants were ranked by the adjusted values for each trait. For
CRAE, the 15% of individuals with the lowest values were defined
as cases, and the 15% with the highest values as controls. For
CRVE, conversely, the 15% with the highest values for were
defined as cases, and the 15% with the lowest values as controls.
Because ANCESTRYMAP uses Bayesian statistics, a prior
distribution of risk models is required [23]. We tested 18 pre-
specified European ancestry risk models to assess overall evidence
of association by averaging across all models. The first 6 models
used 0.4, 0.5, 0.67, 1.5, 2.0 and 2.5-fold risks of being a case due to
inheritance of one copy of an European ancestral allele, with a risk
of 1 for carrying zero copies of an European ancestral allele. The
next 6 models used the same risk set as the first for carrying one
copy of an European ancestral allele, whereas the risk of carrying
zero copies were set to the reciprocal of the risks for carrying one
copy. The last 6 models specified that inheritance of either one or
two copies of an European ancestral allele had a risk of 1, but
carrying zero copies had risks of 0.4, 0.5, 0.67, 1.5, 2.0 and 2.5. By
convention used in the manuscript, a risk ,1.0 for inheritance of
one copy of an European ancestral allele at a given locus
represents a risk model where European ancestry decreases risk
relative to African ancestry. This set of models reflects the
hypothesis that European ancestral alleles are less likely to confer
risks but also tests for the alternative possibilities [23].
ANCESTRYMAP provided two scores to assess statistical
significance: a locus-specific score and a case-control score [23]. A locus-
specific score was obtained in cases (case-only analysis) by calculating
the likelihood of the genotyping data at the SNPs at the locus
under the risk model and comparing it to the likelihood of the
genotyping data at the SNPs at the locus assuming that the locus
is unassociated with the phenotype. The ratio of these two
likelihoods is the ‘‘likelihood ratio’’, and the log-base-10 of this
quantity is the ‘‘LOD’’ score. A locus-specific LOD score of .5
has been recommended as criterion for genome-wide significance
[37]. To obtain an assessment of the evidence for a risk locus
anywhere in the genome, we averaged the likelihood ratio for
association across all loci in the genome, and took the log10 to
obtain a ‘‘genome-wide score’’. We interpreted a genome-wide
score .2 as significant [37].
A case-control score was calculated by comparing locus-specific
deviations in European ancestry in cases versus controls at each
locus across the genome. This score tests whether any deviation in
ancestry from the genome-wide average is significantly different
comparing cases with controls [23]. If there is no locus associated
with phenotype, the case-control score is expected to be dis-
tributed approximately according to a standard normal distribu-
tion. For loci identified by the case-control score, the level of
genome-wide significance was defined as a Z score .4.06 or
,24.06, corresponding to an uncorrected nominal P,5610
25,
or a corrected nominal P,0.05 after conservatively correcting for
1,000 hypotheses tested (approximately equals the number of
independent chromosomal chunks assigned to either African or
European ancestry).
Assessing association of the retinal venular caliber to
local ancestry at admixture-generated signals
The main admixture scans were based on a dichotomous
phenotype (i.e., cases and controls) in a subset of our samples. To
check whether the results were consistent in our entire sample, we
used the ANCESTRYMAP software to obtain local estimates of
African ancestry at the admixture peak [23], and then assessed the
association of the local ancestry with retinal venular caliber as a
continuous trait using linear regression models. Using ANCES-
TRYMAP, we also obtained regional estimates of ancestry based
on the SNPs on chromosome 6p in the admixture panel. In
addition to the five covariates used in the main admixture scans,
CRVE was further adjusted for HDL cholesterol, LDL cholesterol
and plasma triglyceride level, BMI, smoking, and alcohol
consumption, all of which covariates have been shown to affect
retinal vascular calibers [6–8,14]. We then performed a normal-
quantile transformation for CRVE to ensure normality. In the
linear regression models, the transformed CRVE was used as a
dependent variable and the local estimates of ancestry as an
independent variable. To determine whether there was evidence
of residual association with local ancestry after adjustment for
global and regional ancestry, we included each individual’s PAA
and estimated regional ancestry on chromosome 6p as covariates
in the regression models. This enabled us to increase power by
including all samples in a quantitative analysis, rather than using
only a subset of samples with the highest 15% and lowest 15%
values in the dichotomous admixture scans described above. To
determine whether the association between the local ancestry and
CRVE differed significantly by hypertension status, Z tests were
used to compare the difference in the regression coefficients
obtained from the hypertensive and non-hypertensive groups.
Credible interval for the position of a genetic locus
To determine a 95% CI for the position of a trait locus, we
obtained the likelihood ratio for association at each marker on the
chromosome where we identified an association. This provided a
Bayesian posterior probability for the position of the underlying
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for the position of the trait locus. We defined the CI as the central
region of this peak containing 95% of the area.
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